Bausch + Lomb News

Bausch + Lomb Receives FDA Approval of Lumify – The Only Over-the-Counter (OTC) Eye Drop with Low-Dose Brimonidine for the Treatment of Ocular Redness

Bausch + Lomb, a leading global eye health company, announced that the U.S. Food and Drug Administration (FDA) has approved LUMIFY™ (brimonidine tartrate ophthalmic solution 0.025%) as the first and only over-the-counter (OTC) eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness. Brimonidine has been clinically proven to be safe and effective since its initial approval as a prescription medication in 1996 for intraocular pressure (IOP) reduction in glaucoma patients, and is available at higher doses in prescription ophthalmic products.

http://www.bausch.com/our-company/recent-news/id/2403/1172018-wednesday

Bausch + Lomb Signs Agreement with IDOC to Expand Offering of Leading Contact Lenses and Specialty Vision Products

Bausch + Lomb, a leading global eye health company, announced an agreement with IDOC, the largest privately held alliance of independent doctors of optometry in the U.S. Under terms of the agreement, IDOC will offer its more than 3,000 members the Bausch + Lomb ULTRA® contact lenses, the fastest-growing family of monthly planned replacement contact lenses1, Biotrue® ONEday daily disposable contact lenses, the fastest-growing family of daily disposable hydrogels2, and brands from its Specialty Vision Products portfolio, including Bausch + Lomb Zenlens™ and Zen™ RC scleral lenses. IDOC members will also receive exclusive pricing and rebate programs, and exceptional support as the organization’s newest industry affiliate.

http://www.bausch.com/our-company/recent-news/id/2406/2282018-wednesday

Bausch + Lomb Signs Agreement with Express Scripts, Inc., Expanding Insurance coverage of Vyzulta™ (Latanoprostene Bunod Ophthalmic Solution), 0.024%

Bausch + Lomb, a leading global eye health company, today announced an agreement with Express Scripts, Inc. to begin coverage of VYZULTA™ (latanoprostene bunod ophthalmic solution), 0.024%. Under the agreement, VYZULTA is covered under an access position on both the commercial Express Scripts National Preferred and Basic formularies, giving access to an additional 23 million people in the United States. VYZULTA, the first prostaglandin analog with one of its metabolites being nitric oxide (NO), is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

http://www.bausch.com/our-company/recent-news/id/2407/3122017-monday

Bausch + Lomb Receives 510(K) Clearance from FDA for Boston® Scleral Lens Case
First Contact Lens Case Specifically Designed for Storage of Scleral Lenses

Bausch + Lomb, a leading global eye health company, today announced that the company’s Specialty Vision Products business has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for the Boston® scleral lens case, a storage case developed specifically for scleral lenses. The case is designed to hold lenses up to 23.5 millimeters in diameter and up to 10.0 millimeters in sagittal depth. The Boston® scleral lens case is indicated for use with Boston® original conditioning solution, Boston Advance® formula conditioning solution and Boston Simplus® multi-action solution.

http://www.bausch.com/our-company/recent-news/id/2411/4182018-wednesday

Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through One by One Program, Saves More than 14,000 Pounds of Waste

Bausch + Lomb, a leading global eye health company, announced today that its ONE by ONE Recycling Program, the first contact lens recycling program of its kind, has recycled nearly 2.5 million used contact lenses, blister packs and top foil since launch, saving more than 14,000 pounds of waste—about the weight of a small aircraft.1 This program, made possible through a collaboration with TerraCycle®, a world leader in the collection and repurposing of hard-to-recycle post-consumer waste, is offered free of charge to eye care professionals nationwide and their patients.

Available to optometry practices and their patients across the U.S., the Bausch + Lomb ONE by ONE Recycling Program recycles used contact lens materials into post-consumer products. The program works by providing participating practices with large recycling bins to collect used contact lenses, blister packs and top foil. Once the bins are full, a free shipping label can be printed from www.BauschRecycles.com, and the used materials can be mailed to TerraCycle for recycling. For every qualifying shipment of 2 pounds or more, a $1-per-pound donation will be made to Optometry Giving Sight, the only global fundraising initiative that specifically targets the prevention of blindness and impaired vision by providing eye exams and glasses to those in need. To date, the program has raised more than $14,000.

http://www.bausch.com/our-company/recent-news/id/2412/4192018-thursday

 


-- Download Bausch + Lomb News as PDF --